{"DataElement":{"publicId":"12922548","version":"1","preferredName":"Exposure as Collected Domain Dose Interruption Reason","preferredDefinition":"The reason that specifies why the dose was interrupted.","longName":"EC_ECITRPRS","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"12922547","version":"1","preferredName":"Exposure as Collected Domain Dose Interruption Reason","preferredDefinition":"This interventions domain model reflects protocol-specified study treatment administrations, as collected.:A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._A time interval during which there is a temporary cessation of something._An explanation of the cause of some phenomenon or action.","longName":"6407207v1.00:12922546v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6407207","version":"1","preferredName":"Exposure as Collected Domain","preferredDefinition":"This interventions domain model reflects protocol-specified study treatment administrations, as collected.","longName":"C117466","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exposure as Collected Domain","conceptCode":"C117466","definition":"This interventions domain model reflects protocol-specified study treatment administrations, as collected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F33148-F476-0CC0-E053-F662850A951E","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"12922546","version":"1","preferredName":"Dose Interruption Reason","preferredDefinition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._A time interval during which there is a temporary cessation of something._An explanation of the cause of some phenomenon or action.","longName":"C25488:C25542:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Interruption","conceptCode":"C25542","definition":"A time interval during which there is a temporary cessation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5610243-9C9F-2F47-E053-731AD00A45EE","latestVersionIndicator":"Yes","beginDate":"2023-02-23","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-23","modifiedBy":"MMADDINENI","dateModified":"2023-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5610243-9CA0-2F47-E053-731AD00A45EE","latestVersionIndicator":"Yes","beginDate":"2023-02-23","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-23","modifiedBy":"MMADDINENI","dateModified":"2023-06-07","changeDescription":null,"administrativeNotes":"06/07/2023- Reviewed and released -MM","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7426104","version":"1","preferredName":"Dose Delay Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._An explanation of the cause of some phenomenon or action._Specified quantity of a medicine, to be taken at one time or at stated intervals. [ISO 11615:2012 Health Informatics]_Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.","longName":"7426104v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Mucositis (Grade 3 or greater)","valueDescription":"Mucositis","ValueMeaning":{"publicId":"7492308","version":"1","preferredName":"Mucositis","longName":"7492308","preferredDefinition":"Inflammation of the mucous membranes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucositis","conceptCode":"C115965","definition":"Inflammation of the mucous membranes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36195B7-8A96-2214-E053-4EBD850A71FB","latestVersionIndicator":"Yes","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B36195B7-8AAF-2214-E053-4EBD850A71FB","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","deletedIndicator":"No"},{"value":"Elevated creatinine (Grade 2 or greater)","valueDescription":"Elevated Creatinine","ValueMeaning":{"publicId":"7492335","version":"1","preferredName":"Elevated Creatinine","longName":"7492335","preferredDefinition":"Raised or increased above normal levels or limits.: The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Creatinine","conceptCode":"C399","definition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3633393-27DE-4DF6-E053-4EBD850AA12E","latestVersionIndicator":"Yes","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3633393-27F7-4DF6-E053-4EBD850AA12E","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","deletedIndicator":"No"},{"value":"Low platelets (Grade 1 or greater)","valueDescription":"Low Platelet Count","ValueMeaning":{"publicId":"7492332","version":"1","preferredName":"Low Platelet Count","longName":"7492332","preferredDefinition":"A minimum level or position or degree; less than normal in degree, intensity or amount.: The determination of the number of platelets in a blood sample, usually expressed as platelets per cubic millimeter (cmm) of whole blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low","conceptCode":"C54722","definition":"A minimum level or position or degree; less than normal in degree, intensity or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Platelet Count","conceptCode":"C51951","definition":"The determination of the number of platelets in a biospecimen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3630871-3701-2D20-E053-4EBD850A4D7D","latestVersionIndicator":"Yes","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3630871-371A-2D20-E053-4EBD850A4D7D","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","deletedIndicator":"No"},{"value":"Elevated ALT/AST (Grade 4)","valueDescription":"Laboratory Test Result Elevated","ValueMeaning":{"publicId":"7549569","version":"1","preferredName":"Laboratory Test Result Elevated","longName":"7549569","preferredDefinition":"The outcome of a laboratory test.: Raised or increased above normal levels or limits.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Test Result","conceptCode":"C36292","definition":"The outcome of a laboratory test.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8E359FD-30AD-2B6C-E053-4EBD850AE73C","latestVersionIndicator":"Yes","beginDate":"2021-01-14","endDate":null,"createdBy":"WOODC","dateCreated":"2021-01-14","modifiedBy":"ONEDATA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8E359FD-30C6-2B6C-E053-4EBD850AE73C","beginDate":"2021-01-14","endDate":null,"createdBy":"WOODC","dateCreated":"2021-01-14","modifiedBy":"ONEDATA","dateModified":"2021-01-14","deletedIndicator":"No"},{"value":"Elevated liver enzymes","valueDescription":"Elevated Liver Enzyme","ValueMeaning":{"publicId":"2801062","version":"1","preferredName":"Elevated Liver Enzyme","longName":"2801062","preferredDefinition":"Elevated; raised or increased.: A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.: A protein that speeds up chemical reactions in the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Enzyme","conceptCode":"C16554","definition":"Molecules that catalyze a chemical reaction. They are usually proteins, although catalytic RNA and DNA molecules have been identified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BADD682-A47E-6FD9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B013BB72-7FF1-4024-E053-4EBD850A9193","beginDate":"2020-09-18","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-24","modifiedBy":"ONEDATA","dateModified":"2020-09-24","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"3126125","version":"1","preferredName":"Other","longName":"3126125","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D01180C-814A-B8B4-E040-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":"2023.3.7 Alt VM added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF99C7AB-518E-7ADD-E053-4EBD850A0B37","beginDate":"2020-09-18","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-18","modifiedBy":"ONEDATA","dateModified":"2020-09-18","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infection","ValueMeaning":{"publicId":"6610519","version":"1","preferredName":"Infection","longName":"6610519","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F7FD6EF-C887-4DB3-E053-F662850AB340","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF99C7AB-5198-7ADD-E053-4EBD850A0B37","beginDate":"2020-09-18","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-18","modifiedBy":"ONEDATA","dateModified":"2020-09-18","deletedIndicator":"No"},{"value":"Renal dysfunction","valueDescription":"Renal Dysfunction","ValueMeaning":{"publicId":"7415464","version":"1","preferredName":"Renal Dysfunction","longName":"7415464","preferredDefinition":"Of or pertaining to the kidney.: Disturbance, impairment or abnormality of function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal","conceptCode":"C25225","definition":"Of or pertaining to the kidney.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dysfunction","conceptCode":"C53526","definition":"Disturbance, impairment or abnormality of function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF0C2512-61E4-3689-E053-4EBD850A6A69","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"TAYLORT","dateModified":"2020-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF99C7AB-51A2-7ADD-E053-4EBD850A0B37","beginDate":"2020-09-18","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-18","modifiedBy":"ONEDATA","dateModified":"2020-09-18","deletedIndicator":"No"},{"value":"Elevated triglycerides","valueDescription":"Elevated Triglycerides","ValueMeaning":{"publicId":"7426106","version":"1","preferredName":"Elevated Triglycerides","longName":"7426106","preferredDefinition":"Raised or increased above normal levels or limits.: Fats composed of three fatty acid chains linked to a glycerol molecule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Triglycerides","conceptCode":"C906","definition":"Fats composed of three fatty acid chains linked to a glycerol molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF99C7AB-51D6-7ADD-E053-4EBD850A0B37","latestVersionIndicator":"Yes","beginDate":"2020-09-18","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-18","modifiedBy":"ONEDATA","dateModified":"2020-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF99C7AB-51EF-7ADD-E053-4EBD850A0B37","beginDate":"2020-09-18","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-18","modifiedBy":"ONEDATA","dateModified":"2020-09-18","deletedIndicator":"No"},{"value":"Elevated direct bilirubin (greater than 2mg/dL)","valueDescription":"Elevated Direct Bilirubin Measurement","ValueMeaning":{"publicId":"7492334","version":"1","preferredName":"Elevated Direct Bilirubin Measurement","longName":"7492334","preferredDefinition":"Raised or increased above normal levels or limits.: The bilirubin is bound to glucuronide to form conjugated bilirubin (direct bilirubin). Direct Bilirubin measurement is accomplished by a colorimetric method. Direct Bilirubin in biological fluids reacts with sulfanilic acid at acidic pH to produce a red colored complex. The optical density of produced color has a direct relationship with Direct Bilirubin concentration in the solution.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Direct Bilirubin Measurement","conceptCode":"C64481","definition":"The bilirubin is bound to glucuronide to form conjugated bilirubin (direct bilirubin). Direct Bilirubin measurement is accomplished by a colorimetric method. Direct Bilirubin in biological fluids reacts with sulfanilic acid at acidic pH to produce a red colored complex. The optical density of produced color has a direct relationship with Direct Bilirubin concentration in the solution.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3632E57-E151-5288-E053-4EBD850A0271","latestVersionIndicator":"Yes","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3632E57-E16A-5288-E053-4EBD850A0271","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","deletedIndicator":"No"},{"value":"Elevated ALT (Grade 3 or greater)","valueDescription":"Elevated Alanine Aminotransferase Measurement","ValueMeaning":{"publicId":"7492333","version":"1","preferredName":"Elevated Alanine Aminotransferase Measurement","longName":"7492333","preferredDefinition":"Raised or increased above normal levels or limits.: A quantitative measurement of alanine aminotransferase present in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Alanine Aminotransferase Measurement","conceptCode":"C64433","definition":"A quantitative measurement of alanine aminotransferase present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3629F69-E50B-2A17-E053-4EBD850ADBCF","latestVersionIndicator":"Yes","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3629F69-E524-2A17-E053-4EBD850ADBCF","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","deletedIndicator":"No"},{"value":"Low ANC (Grade 3 or greater)","valueDescription":"Low Absolute Neutrophil Count","ValueMeaning":{"publicId":"7492330","version":"1","preferredName":"Low Absolute Neutrophil Count","longName":"7492330","preferredDefinition":"A minimum level or position or degree; less than normal in degree, intensity or amount.: The real number of white blood cells (WBC) that are neutrophils. It is derived by multiplying the WBC count by the percent of neutrophils in the differential WBC count. The normal range for ANC is 1.5 to 8.0 (1,500 to 8,000/mm3).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low","conceptCode":"C54722","definition":"A minimum level or position or degree; less than normal in degree, intensity or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Absolute Neutrophil Count","conceptCode":"C63321","definition":"The real number of white blood cells (WBC) that are neutrophils. It is derived by multiplying the WBC count by the percent of neutrophils in the differential WBC count. The normal range for ANC is 1.5 to 8.0 (1,500 to 8,000/mm3).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3629F69-E4E3-2A17-E053-4EBD850ADBCF","latestVersionIndicator":"Yes","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3629F69-E4FC-2A17-E053-4EBD850ADBCF","beginDate":"2020-11-05","endDate":null,"createdBy":"WOODC","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","deletedIndicator":"No"},{"value":"Low platelets (Grade 3 or greater)","valueDescription":null,"ValueMeaning":{"publicId":"12922540","version":"1","preferredName":"Low Platelet Count","longName":"12922540v1.00","preferredDefinition":"A lower than average level of platelets in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Platelet Count","conceptCode":"C162108","definition":"A lower than average level of platelets in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F560907A-5ECA-1670-E053-731AD00AB82C","latestVersionIndicator":"Yes","beginDate":"2023-02-23","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-23","modifiedBy":"MMADDINENI","dateModified":"2023-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F560907A-5ECB-1670-E053-731AD00AB82C","beginDate":"2023-02-23","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-23","modifiedBy":"MMADDINENI","dateModified":"2023-02-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7434008","version":"1","preferredName":"Dose Delay Reason","preferredDefinition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.:Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.:An explanation of the cause of some phenomenon or action.","longName":"C25488:C25476:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Delay","conceptCode":"C25476","definition":"Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B01238FC-4738-7D4F-E053-4EBD850A438E","latestVersionIndicator":"Yes","beginDate":"2020-09-24","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-24","modifiedBy":"ONEDATA","dateModified":"2020-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF99C7AB-517A-7ADD-E053-4EBD850A0B37","latestVersionIndicator":"Yes","beginDate":"2020-09-18","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-18","modifiedBy":"MMADDINENI","dateModified":"2023-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"EC_ECITRPRS_6MP","type":"COG GDE Short Name","context":"COG"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"If yes, reason for dose interruption:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F56143C0-C685-3ABC-E053-731AD00A4368","latestVersionIndicator":"Yes","beginDate":"2023-02-23","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-02-23","modifiedBy":"MMADDINENI","dateModified":"2023-06-07","changeDescription":null,"administrativeNotes":"06/07/2023-Reviewed and released-MM","unresolvedIssues":null,"deletedIndicator":"No"}}